Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-017520-88Phase 4Terminated
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Ciclosporin microemulsion arm with Alitretinoin arm (2 arms). Primary endpoint: Mean relative change in HECSI score. Started Aug 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-017520-88.